CD133 expression predicts post-operative recurrence in patients with colon cancer with peritoneal metastasis

MLA

Kazushige Kawai, et al. “CD133 Expression Predicts Post-Operative Recurrence in Patients with Colon Cancer with Peritoneal Metastasis.” International Journal of Oncology, vol. 52, no. 3, Jan. 2018, pp. 721–32. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....51a111634153ab549616ac7c8eb41f3e&authtype=sso&custid=ns315887.

APA

Kazushige Kawai, Hiroaki Nozawa, Keisuke Hata, Koji Murono, Tomomichi Kiyomatsu, Hirofumi Sonoda, Kazuhito Sasaki, Manabu Kaneko, Junko Kishikawa, Takeshi Nishikawa, Kensuke Otani, Shigenobu Emoto, Soichiro Ishihara, Hiroshi Nagata, & Toshiaki Tanaka. (2018). CD133 expression predicts post-operative recurrence in patients with colon cancer with peritoneal metastasis. International Journal of Oncology, 52(3), 721–732.

Chicago

Kazushige Kawai, Hiroaki Nozawa, Keisuke Hata, Koji Murono, Tomomichi Kiyomatsu, Hirofumi Sonoda, Kazuhito Sasaki, et al. 2018. “CD133 Expression Predicts Post-Operative Recurrence in Patients with Colon Cancer with Peritoneal Metastasis.” International Journal of Oncology 52 (3): 721–32. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....51a111634153ab549616ac7c8eb41f3e&authtype=sso&custid=ns315887.